Market Insights for Novel Drug Delivery Systems in Cancer Therapy by Type, Industry, Application, and End-User | FMI
The Novel Drug Delivery Systems In The Cancer Therapy Market are predicted to account for US$ 88.5 billion in 2032, up from US$ 14.8 billion in 2022, advancing at a CAGR of 19.6% during the forecast period (2022-2032). Rising cancer awareness and prevalence around the world, as well as increased adoption of novel drug delivery systems in cancer therapy with fewer side effects, are driving demand for novel drug delivery systems in cancer therapy. The high cost of therapy may stifle the growth of novel drug delivery systems in the cancer therapy market over the forecast period. The rise of novel drug delivery systems in cancer therapy market statistics is expected to be hampered by a lack of awareness about alternative medications and a lack of funds for their development. COVID-19 has a negative impact on the global market for novel drug delivery systems in cancer therapy. Furthermore, consumer demand has decreased as people are now more focused on removing non-essentia...